As per the regulations changes, we require to change the name from hold to interruption form. This is used when the SIMG's are required some time off of the pathway process.

Alert update May 2023: Periprocedural diabetic ketoacidosis (DKA) with sodium-glucose co-transporter-2 inhibitor use in people with diabetes.

Use this checklist for endorsement criteria to become endorsed in pain medicine procedures via the practice assessment pathway